Neuman Systems Model-Based Yoga Therapy for Test Anxiety in Secondary School Students

NCT07644182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2026-06-12

No results posted yet for this study

Summary

This cluster randomized controlled trial evaluates the effects of a yoga therapy program grounded in the Neuman Systems Model on test anxiety, quality of life, and mindfulness among eighth-grade students aged 13-14 years in Denizli, Türkiye. The study was conducted with students preparing for the national High School Entrance System (LGS) examination. A total of 166 eighth-grade students were allocated to intervention and control groups at the school level. The intervention consisted of a structured yoga therapy program delivered once weekly for four weeks. Outcomes were assessed using standardized measures of test anxiety, quality of life, and mindfulness at baseline, mid-intervention, and post-intervention. The study received ethics committee approval, institutional permissions, and written informed consent from parents or legal guardians.

Conditions

  • Test Anxiety in Adolescents

Interventions

BEHAVIORAL

School-Based Yoga Therapy Program

Participants received a structured school-based yoga intervention based on the Neuman Systems Model, including breathing exercises, physical postures, relaxation, and mindfulness practices. The intervention was delivered during school hours in structured sessions over a defined intervention period. The aim was to reduce test anxiety and improve mindfulness and quality of life among secondary school students.

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-05-21
Completion
2026-05-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07644182 on ClinicalTrials.gov